Population pharmacokinetics and pharmacodynamics of edoxaban in pediatric patients
Abstract Edoxaban is an orally active inhibitor of activated factor X (FXa). Population pharmacokinetic (PK) and pharmacodynamic (PD) analyses were performed to characterize the PK and PK–PD relationships of edoxaban in pediatric patients to identify the covariates that may contribute to inter‐subje...
Saved in:
Main Authors: | Peng Zou, Akhilesh Atluri, Peter Chang, Michael Goedecke, Tarek A. Leil |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.13248 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic and pharmacodynamic data analysis : concepts and applications /
by: Gabrielsson, Johan
Published: (2016) -
Vancomycin population pharmacokinetic models: Uncovering pharmacodynamic divergence amid clinicobiological resemblance
by: Peggy Gandia, et al.
Published: (2025-01-01) -
Pharmacokinetics and pharmacodynamics of ciprofol after continuous infusion in elderly patients
by: Xiaowen Guo, et al.
Published: (2025-01-01) -
The Clinical Pharmacokinetics and Pharmacodynamics of Glimepiride—A Systematic Review and Meta-Analysis
by: Mubara Azhar, et al.
Published: (2025-01-01) -
Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
by: Yangyang Gao, et al.
Published: (2025-01-01)